Literature DB >> 314780

Abnormal laboratory test results and their relationship to prognosis in discoid lupus erythematosus. A long-term follow-up study of 92 patients.

L G Millard, N R Rowell.   

Abstract

Investigation of 92 patients with discoid lupus erythematosus, manifested initially by localized cutaneous lesions only, showed abnormal laboratory test results for 57 patients (62%) on admission and for 62 patients (67.4%) on review 16 to 20 years later. Patients with discoid lesions confined to the head and neck (DLE) showed fewer laboratory abnormalities than those patients with disseminated lesions involving trunk and limbs (disseminated discoid lupus erythematosus [DDLE]). Systemic lupus erythematosus (SLE) eventually developed in six (6.5%) of the patients, and all had shown persistent multiple abnormal laboratory findings from the beginning. Complete remission occurred in 46.7%. A persistent positive antinuclear factor of either speckled or homogeneous pattern with a titer greater than 1:50, leukopenia, thrombocytopenia, or a false-positive Wassermann reaction indicated those patients who may progress to DDLE or SLE.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 314780

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  8 in total

1.  Autoantibodies to evolutionarily conserved epitopes of enolase in a patient with discoid lupus erythematosus.

Authors:  V M Gitlits; J W Sentry; M L Matthew; A I Smith; B H Toh
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

2.  A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus.

Authors:  R Vasquez; D Wang; Q P Tran; B Adams-Huet; M-M Chren; M I Costner; J B Cohen; V P Werth; B F Chong
Journal:  Br J Dermatol       Date:  2012-09-13       Impact factor: 9.302

3.  Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.

Authors:  Yesenia Santiago-Casas; Luis M Vilá; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Elizabeth E Brown
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

4.  Cutaneous lupus erythematosus--a study of clinical and laboratory prognostic factors in 65 patients.

Authors:  E Healy; E Kieran; S Rogers
Journal:  Ir J Med Sci       Date:  1995 Apr-Jun       Impact factor: 1.568

5.  IgG and IgM autoantibody differences in discoid and systemic lupus patients.

Authors:  Benjamin F Chong; Lin-chiang Tseng; Thomas Lee; Rebecca Vasquez; Quan Z Li; Song Zhang; David R Karp; Nancy J Olsen; Chandra Mohan
Journal:  J Invest Dermatol       Date:  2012-07-05       Impact factor: 8.551

6.  B cell subset composition segments clinically and serologically distinct groups in chronic cutaneous lupus erythematosus.

Authors:  Scott A Jenks; Chungwen Wei; Regina Bugrovsky; Aisha Hill; Xiaoqian Wang; Francesca M Rossi; Kevin Cashman; Matthew C Woodruff; Laura D Aspey; S Sam Lim; Gaobin Bao; Cristina Drenkard; Ignacio Sanz
Journal:  Ann Rheum Dis       Date:  2021-06-03       Impact factor: 27.973

Review 7.  A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus.

Authors:  Paul Curtiss; Amanda M Walker; Benjamin F Chong
Journal:  Front Immunol       Date:  2022-03-11       Impact factor: 7.561

8.  Discoid lupus erythematosus in Iraqi patients: a clinical and histopathological study.

Authors:  Mohammed Kadhim Al-Hattab; Makram Al-Waiz
Journal:  Ann Saudi Med       Date:  2004 Jul-Aug       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.